Steve E. Krognes
2018
In 2018, Steve E. Krognes earned a total compensation of $4M as Chief Financial Officer and Treasurer at Denali Therapeutics, a 243% increase compared to previous year.
Compensation breakdown
Bonus | $393,682 |
---|---|
Option Awards | $2,948,616 |
Salary | $455,260 |
Stock Awards | $179,673 |
Other | $24,000 |
Total | $4,001,231 |
Krognes received $2.9M in option awards, accounting for 74% of the total pay in 2018.
Krognes also received $393.7K in bonus, $455.3K in salary, $179.7K in stock awards and $24K in other compensation.
Rankings
In 2018, Steve E. Krognes' compensation ranked 2,788th out of 14,244 executives tracked by ExecPay. In other words, Krognes earned more than 80.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,788 | 80th |
Manufacturing | 1,034 | 82nd |
Chemicals And Allied Products | 354 | 83rd |
Drugs | 291 | 84th |
Biological Products, Except Diagnostic Substances | 63 | 81st |
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2018.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019